Brainstorm Cell Therapeutics Inc. Liquidation Value
BCLI
Other
Cash & Equivalents
$29,000
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $29,000
Total Obligations: -$11.21M
$-11.19M
Per share: $-1.01
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $29,000
AR: $0
Total Obligations: -$11.21M
$-11.19M
Per share: $-1.01
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $29,000
AR: $0
Inventory: $0
Total Obligations: -$11.21M
$-11.19M
Per share: $-1.01
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-11.19M | $-1.01 |
| Liquid Liquidation Value | $-11.19M | $-1.01 |
| Operating Liquidation Value | $-11.19M | $-1.01 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $29,000 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $11.01M |
| Long-term Debt | N/A |
| Op. Lease Liability | $208,000 |
| Finance Lease | N/A |
| Shares Outstanding | 11.0M |
Explore all 81 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $29,000 | N/A | N/A | $7.07M | $11.01M | N/A | $208,000 | N/A |
| 2025-09-30 | $5,000 | N/A | N/A | $6.42M | $9.02M | N/A | $326,000 | N/A |
| 2025-06-30 | $824,000 | N/A | N/A | $6.00M | $8.53M | N/A | $476,000 | N/A |
| 2025-03-31 | $1.64M | N/A | N/A | $6.80M | $10.90M | N/A | $570,000 | N/A |
▼ Community Notes